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Evidence for a role of GluN2C/GluN2D-containing 
NMDA receptors in neuronal oscillations
John Doran, Tyler Miller, Kiran Sapkota, and Daniel T. Monaghan
University of Nebraska Medical Center, Omaha, NE
Results
UBP791 robustly increased the amplitude of gamma wave
oscillations (band above 30 Hz). These are high frequency
EEG wave patterns that are associated with hyper brain
activity. High gamma oscillations returned to baseline
towards the end of the recording while low gamma
frequencies remained elevated.
Conclusion
Because UBP791 is a selective GluN2C/2D NMDAR
antagonist, the data suggests that blocking GluN2C and
GluN2D receptor subtypes induces hyperactive brain
function throughout the cortex. Because augmentation of
gamma oscillations is a correlate of schizophrenia, these
results suggest that a selective potentiator of GluN2C/2D
NMDARs may be of therapeutic benefit in schizophrenia.
This information may help future research determine how
abnormalities in each NMDA receptor subtype may
contribute to schizophrenia and other brain pathologies.
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Background
Synchronization of neuronal firing leads to neural oscillations
(brain waves) which are critical to working memory,
cognition, and perception. NMDA receptors (NMDARs) play a
vital role in establishing appropriate neural oscillations and
modulating brain activity. Abnormalities in NMDARs have
been linked to diseases such as schizophrenia causing
impairments in working memory, cognition, and perception,
which is thought to be due to abnormal brain wave patterns.
Consistent with this hypothesis, general NMDA receptor
blockers produce exaggerated neuronal oscillations and
schizophrenia-like symptoms. Several NMDAR subtypes
exist, and novel disease treatments may depend on targeting
a select group of NMDAR subtypes. The drug UBP791 is a
competitive antagonist that has a higher binding affinity for
GluN2C/2D over GluN2A/2B. The selectivity of UBP791
allows for discrimination between these receptor subtypes
and identifying the role of various NMDARs.
Purpose
Observing UBP791’s effect on brain activity may help identify





1. Implanted electrodes into rat brain (see 
electrode locations to the right)
2. Allowed rat to recover from surgery
3. Connected wireless transmitter to  
electrodes 
4. Recorded baseline brain activity using     
EEG technology
5. Injected rat with 15 mg/kg UBP791
6. Recorded new brain activity
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